Assignee
SPERO THERAPEUTICS INC
US·7 granted patents·6 pending applications·4 citations·filing 2017–2024
Top patents by PatentIndex Score
13 records- 0183US12048691B2High dosage tebipenem pivoxil tablet formulationSPERO THERAPEUTICS INC·Filed 2021·Granted Jul 30, 2024·1 cites·25 claims
- 0283US2025051334A1Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0382US12098155B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·0 cites·16 claims
- 0479US10889587B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2018·Granted Jan 12, 2021·1 cites·16 claims
- 0574US11459357B2Polymyxin compoundsSPERO THERAPEUTICS INC·Filed 2019·Granted Oct 4, 2022·2 cites·14 claims
- 0672US11718621B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2020·Granted Aug 8, 2023·0 cites·16 claims
- 0771US2023322858A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0869US2025049766A1High dosage tebipenem pivoxil tablet formulationSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0967US2025009718A1Tebipenem pivoxil immediate and modified release oral dosage formsSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1066US12528837B2Aryl substituted polymyxin derivativesSPERO THERAPEUTICS INC·Filed 2022·Granted Jan 20, 2026·0 cites·19 claims
- 1164US2024366599A1Human efficacious dose and dosage schedule of spr720SPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1259US2021221848A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1357US12226403B2Tebipenem pivoxil immediate and modified release oral dosage formsSPERO THERAPEUTICS INC·Filed 2017·Granted Feb 18, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when SPERO THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →